Artificial Blood and Oxygen Carriers The Next Revolution in Intraoperative Safety Abstract The development of artificial blood and oxygen carrying substitutes represents a significant milestone in perioperative medicine, offering potential solutions to persistent challenges surrounding blood transfusion safety, supply constraints, and compatibility. Although allogeneic blood transfusion remains a
Author: Nancy Ogbonna
Comorbid Insomnia: New Research Reveals Bidirectional Mental Health Links
Comorbid Insomnia New Research Reveals Bidirectional Mental Health Links Introduction Comorbid insomnia represents a substantial and often underrecognized public health challenge, affecting an estimated 25 million individuals in the United States each year and contributing to approximately $100 billion in annual healthcare expenditures. Sleep
Platelet Function Testing vs Standard Care: What Clinical Data Really Shows
Platelet Function Testing vs Standard Care What Clinical Data Really Shows Introduction High on treatment platelet reactivity remains a significant clinical challenge in patients receiving clopidogrel, with approximately one in three treated individuals demonstrating inadequate platelet inhibition. This variability in response has important therapeutic
Targeting α-Synuclein: The Next Frontier in Parkinson’s Therapy
Targeting α-Synuclein The Next Frontier in Parkinson’s Therapy Abstract Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease, affecting an estimated 10 million individuals worldwide. Its prevalence is expected to rise substantially with population aging, creating an expanding clinical and socioeconomic
Thyroid Cancer Overdiagnosis: When Screening Causes More Harm Than Good
Thyroid Cancer Overdiagnosis When Screening Causes More Harm Than Good Abstract The incidence of thyroid cancer has risen substantially over the past three decades, drawing increased attention from clinicians, researchers, and public health authorities. Much of this rise has been attributed not to a true surge in aggressive
Why GLP-1 Receptor Agonists Are Becoming Essential Cardiovascular Drugs
Why GLP-1 Receptor Agonists Are Becoming Essential Cardiovascular Drugs Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a transformative class of medications in the management of type 2 diabetes, demonstrating an approximate 14 percent reduction in major adverse cardiovascular events. Initially developed
Medical Alert Watch Technology: From Detection to Emergency Response in Minutes
Why Biomarker-Driven Treatment Fails: The Hidden Role of Histology
Why Biomarker-Driven Treatment Fails The Hidden Role of Histology Introduction Biomarker-driven treatment has fundamentally transformed oncology, ushering in an era of precision medicine in which therapeutic decisions are increasingly guided by the molecular characteristics of tumors rather than their anatomical origin alone. A
Targeting the Bone Marrow Microenvironment in Myeloma and Acute Myeloid Leukemia: Novel Therapeutic Approaches and Clinical Implications
Targeting the Bone Marrow Microenvironment in Myeloma and Acute Myeloid Leukemia Novel Therapeutic Approaches and Clinical Implications Abstract The bone marrow microenvironment is increasingly recognized as a central determinant in the initiation, progression, and therapeutic resistance of hematologic malignancies, particularly multiple myeloma and acute myeloid leukemia
Prediabetes Management in Family Practice: Comparative Effectiveness of Lifestyle Intervention, Metformin, and Anti-Obesity Pharmacotherapy
Prediabetes Management in Family Practice Comparative Effectiveness of Lifestyle Intervention, Metformin, and Anti-Obesity Pharmacotherapy Abstract Prediabetes represents a critical window for intervention in the trajectory toward type 2 diabetes mellitus, offering family physicians an opportunity to prevent or significantly delay disease onset. With global
